AWM
DXCM icon

Abound Wealth Management’s DexCom DXCM Stock Holding History

Abound Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741 Sell
11
-32
-74% -$2.13K ﹤0.01% 874
2026
Q1 		$2.7K Buy
43
+12
+39% +$836 ﹤0.01% 859
2025
Q4 		$2.06K Sell
31
-8
-21% -$517 ﹤0.01% 845
2025
Q3 		$2.63K Buy
39
+8
+26% +$633 ﹤0.01% 770
2025
Q2 		$2.71K Hold
31
– – ﹤0.01% 703
2025
Q1 		$2.12K Sell
31
-20
-39% -$1.63K ﹤0.01% 692
2024
Q4 		$3.97K Sell
51
-2
-4% -$148 ﹤0.01% 574
2024
Q3 		$3.55K Sell
53
-7
-12% -$575 ﹤0.01% 617
2024
Q2 		$6.78K Sell
60
-1
-2% -$126 ﹤0.01% 440
2024
Q1 		$8.44K Sell
61
-6
-9% -$754 ﹤0.01% 406
2023
Q4 		$8.3K Buy
67
+25
+60% +$2.55K ﹤0.01% 404
2023
Q3 		$3.92K Sell
42
-2
-5% -$225 ﹤0.01% 515
2023
Q2 		$5.66K Buy
44
+2
+5% +$242 ﹤0.01% 456
2023
Q1 		$4.88K Buy
42
+10
+31% +$1.12K ﹤0.01% 412
2022
Q4 		$3.62K Sell
32
-64
-67% -$7.03K ﹤0.01% 418
2022
Q3 		$7.73K Buy
+96
New +$8.13K ﹤0.01% 307

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Abound Wealth Management's DXCM Position: Q2 2026 in Review

Abound Wealth Management reduced its DexCom (DXCM) stake by 74% in Q2 2026, selling an estimated $2.13K and leaving 11 shares worth $741. The position accounts for ﹤0.01% of the portfolio, ranked #874.

Abound Wealth Management first reported a position in DXCM in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.44K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Abound Wealth Management held 11 shares of DexCom worth $741 as of Q2 2026.
  • Abound Wealth Management sold 32 DexCom shares in Q2 2026, an estimated $2.13K.
  • DexCom made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #874 holding.
  • Abound Wealth Management first reported a position in DexCom in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's DexCom position peaked at $8.44K in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.